Published on in Vol 6, No 4 (2022): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31629, first published .
Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring–Driven Virtual Care Program: Prospective Study

Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring–Driven Virtual Care Program: Prospective Study

Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring–Driven Virtual Care Program: Prospective Study

Journals

  1. Rosta L, Menyhart A, Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh S, Janez A, Kalra S, Kapoor N, Lessan N, Lotufo P, Papanas N, Rizvi A, Sahebkar A, Santos R, Stoian A, Toth P, Viswanathan V, Kempler P, Rizzo M. Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. Frontiers in Endocrinology 2023;14 View
  2. Reed J, Dong T, Eaton E, Friswold J, Porges J, Al‐Kindi S, Rajagopalan S, Neeland I. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial. Diabetes, Obesity and Metabolism 2024;26(7):2881 View